Malignant Lymphoma of the Lacrimal Gland: A Nation-Based Study | Allergy and Clinical Immunology | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.186.91. Please contact the publisher to request reinstatement.
1.
Swerdlow SH, Campo E, Harris NL,  et al.  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008
2.
Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas.  Cancer. 1972;29(1):252-2605007387PubMedGoogle ScholarCrossref
3.
Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1.  Ophthalmology. 2004;111(5):997-100815121380PubMedGoogle ScholarCrossref
4.
Sjö LD, Ralfkiaer E, Prause JU,  et al.  Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005.  Invest Ophthalmol Vis Sci. 2008;49(8):3283-328818390644PubMedGoogle ScholarCrossref
5.
Coupland SE, Hellmich M, Auw-Haedrich C, Lee WR, Stein H. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.  Graefes Arch Clin Exp Ophthalmol. 2004;242(2):130-14514685876PubMedGoogle ScholarCrossref
6.
Jenkins C, Rose GE, Bunce C,  et al.  Clinical features associated with survival of patients with lymphoma of the ocular adnexa.  Eye (Lond). 2003;17(7):809-82014528242PubMedGoogle ScholarCrossref
7.
Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987.  Hum Pathol. 1990;21(9):959-9732394438PubMedGoogle ScholarCrossref
8.
Knop E, Knop N. The role of eye-associated lymphoid tissue in corneal immune protection.  J Anat. 2005;206(3):271-28515733300PubMedGoogle ScholarCrossref
9.
Dickinson AJ, Gausas RE. Orbital lymphatics: do they exist?  Eye (Lond). 2006;20(10):1145-114817019412PubMedGoogle ScholarCrossref
10.
Kíratlí H, Söylemezoğlu F, Bilgiç S, Ruacan S. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland.  Ophthal Plast Reconstr Surg. 1999;15(4):272-27610432523PubMedGoogle ScholarCrossref
11.
Lin YC, Kau HC, Kao SC, Hsu WM, Tsai CC. Systemically disseminated extranodal marginal zone B-cell lymphoma of lacrimal gland in a patient with systemic lupus erythematosus.  Ophthal Plast Reconstr Surg. 2007;23(1):72-7317237702PubMedGoogle ScholarCrossref
12.
Cassidy DT, McKelvie P, Harris GJ, Rose GE, McNab AA. Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjögren's syndrome.  Orbit. 2005;24(4):257-26316354635PubMedGoogle ScholarCrossref
13.
Farmer JP, Lamba M, Lamba WR,  et al.  Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis.  Can J Ophthalmol. 2005;40(2):151-16016049528PubMedGoogle Scholar
14.
Kao SC, Kau HC, Tsai CC,  et al.  Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type.  Am J Ophthalmol. 2007;143(2):311-31617184716PubMedGoogle ScholarCrossref
15.
 A predictive model for aggressive non-Hodgkin's lymphoma: the International Non-Hodgkin's Lymphoma Prognostic Factors Project.  N Engl J Med. 1993;329(14):987-9948141877PubMedGoogle ScholarCrossref
16.
Coupland SE, White V, Rootman J,  et al.  TNM staging of ocular adnexal lymphomas. In: Edge SE, Byrd DR, Garducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009:583-589
17.
Cheson BD, Pfistner B, Juweid ME,  et al; International Harmonization Project on Lymphoma.  Revised response criteria for malignant lymphoma.  J Clin Oncol. 2007;25(5):579-58617242396PubMedGoogle ScholarCrossref
18.
Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale.  Am J Epidemiol. 1997;145(1):72-808982025PubMedGoogle ScholarCrossref
19.
Dunn P, Kuo TT, Shih LY,  et al.  Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan.  Acta Haematol. 2004;112(4):203-20815564732PubMedGoogle ScholarCrossref
20.
Kojima M, Shimizu K, Nishikawa M,  et al.  Primary salivary gland lymphoma among Japanese: a clinicopathological study of 30 cases.  Leuk Lymphoma. 2007;48(9):1793-179817786716PubMedGoogle ScholarCrossref
21.
Vitali C, Bombardieri S, Jonsson R,  et al; European Study Group on Classification Criteria for Sjögren's Syndrome.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.  Ann Rheum Dis. 2002;61(6):554-55812006334PubMedGoogle ScholarCrossref
22.
Voulgarelis M, Moutsopoulos HM. Lymphoproliferation in autoimmunity and Sjögren's syndrome.  Curr Rheumatol Rep. 2003;5(4):317-32314531960PubMedGoogle ScholarCrossref
23.
Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.  Medicine (Baltimore). 2009;88(5):284-29319745687PubMedGoogle ScholarCrossref
24.
Andersen NS, Jensen MK, de Nully Brown P, Geisler CH. A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors.  Eur J Cancer. 2002;38(3):401-40811818206PubMedGoogle ScholarCrossref
25.
Rasmussen P, Sjö LD, Prause JU, Ralfkiaer E, Heegaard S. Mantle cell lymphoma in the orbital and adnexal region.  Br J Ophthalmol. 2009;93(8):1047-105119429588PubMedGoogle ScholarCrossref
26.
Madge SN, McCormick A, Patel I,  et al.  Ocular adnexal diffuse large B-cell lymphoma: local disease correlates with better outcomes.  Eye (Lond). 2010;24(6):954-96119942938PubMedGoogle ScholarCrossref
27.
Sjö LD, Heegaard S, Prause JU, Petersen BL, Pedersen S, Ralfkiaer E. Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical, and cytogenetical characteristics.  Invest Ophthalmol Vis Sci. 2009;50(2):516-52218775860PubMedGoogle Scholar
Clinical Sciences
Oct 2011

Malignant Lymphoma of the Lacrimal Gland: A Nation-Based Study

Author Affiliations

Author Affiliations: Departments of Neuroscience and Pharmacology, Eye Pathology Section (Drs Rasmussen, Prause, and Heegaard), and Public Health, The Research Unit, Section of General Practice (Dr Siersma), University of Copenhagen; Department of Pathology, Copenhagen University Hospital (Drs Ralfkiaer and Sjö), Copenhagen; and Department of Ophthalmology, Glostrup University Hospital, Glostrup (Dr Heegaard), Denmark.

Arch Ophthalmol. 2011;129(10):1275-1280. doi:10.1001/archophthalmol.2011.270
Abstract

Objective To characterize the clinicopathologic features of lacrimal gland lymphoma.

Methods All cases of lacrimal gland lymphoma from January 1, 1975, through December 31, 2009, were retrieved from The Danish Registry of Pathology. Histologic specimens were reevaluated using a panel of monoclonal antibodies. Clinical files from all patients with confirmed lymphoma were collected.

Results Twenty-seven patients with lacrimal gland lymphoma were identified. Eight of the patients were men and 19 were women; the median (range) age was 69 (43-87) years. The distribution of lymphoma subtypes was as follows: extranodal marginal zone lymphoma, 10 (37%); follicular lymphoma, 5 (19%); diffuse large B-cell lymphoma, 4 (15%); mantle cell lymphoma, 3 (11%); chronic lymphocytic leukemia/small lymphatic lymphoma, 2 (7%); and unclassified B-cell lymphoma, 3 (11%). Twenty-two patients (81%) had stage I or II lymphoma, 1 patient (4%) had stage III lymphoma, and 4 patients (15%) had stage IV lymphoma. Patients with stage I or II lymphoma were treated with radiotherapy (15 [67%]), chemotherapy (3 [14%]), chemotherapy plus radiotherapy (1 [5%]), and surgery (3 [14%]). Patients presenting with stage III or IV lymphoma were treated with chemotherapy alone. Complete remission was observed in 23 of the patients (85%), although 12 (44%) of these had a relapse, independent of subtype, stage, or treatment. The 5-year overall survival was 70%.

Conclusions Malignant lymphoma of the lacrimal gland is relatively rare and is mostly prevalent in elderly women. The distribution of lacrimal gland lymphoma subtypes resembles that of lymphoma subtypes of the salivary glands. The majority of lacrimal gland lymphomas are low grade, and the prognosis is relatively good.

×